Vaxart, Inc. Shareholders' Equity
Vaxart, Inc. (VXRT) had Shareholders' Equity of $82.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $82.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $94.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $87.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $26.76M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $82.37M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $94.12M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $87.80M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $26.76M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $32.88M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $45.62M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $58.92M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $68.44M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $80.01M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $55.69M 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $57.80M S-1 · filed 2026-05-08 | |
| 2023-09-30 | $71.52M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $85.07M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $89.75M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $110.60M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $122.31M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $143.09M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $166.37M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $187.53M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $204.95M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $199.78M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $176.24M 10-Q · filed 2022-08-08 | |
| 2020-12-31 | $123.40M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $131.68M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $40.23M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $31.29M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $12.95M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $18.90M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $15.85M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $12.58M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $11.21M 10-K · filed 2022-02-24 | $11.24M 10-K · filed 2019-02-06 |
| 2018-09-30 | $15.99M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $22.35M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $31.11M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | -$38.72M 10-K · filed 2021-02-25 | $10.80M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $13.90M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $18.70M 10-Q · filed 2018-02-06 | |
| 2017-03-31 | $24.20M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$29.64M 10-K · filed 2019-02-06 | $28.00M 10-Q · filed 2017-02-06 |
| 2016-09-30 | $36.60M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $46.20M 10-K · filed 2017-09-01 | |
| 2016-03-31 | $52.70M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $57.50M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $63.50M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $69.50M 10-K · filed 2017-09-01 | |
| 2015-03-31 | $81.50M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $82.40M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $77.90M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $86.90M 10-K · filed 2016-09-13 | |
| 2014-03-31 | $96.00M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $64.20M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $64.90M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $68.00M 10-K · filed 2016-09-13 | $68.20M 10-K · filed 2013-09-27 |
| 2013-03-31 | $80.10M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $78.96M 10-Q · filed 2013-02-11 | |
| 2012-09-30 | $29.97M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $59.30M 10-K · filed 2015-09-11 | $57.34M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $59.41M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $67.39M 10-Q · filed 2013-02-11 | $58.87M 10-K · filed 2012-03-14 |
| 2011-09-24 | $60.69M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $81.40M 10-K · filed 2014-09-30 | $81.43M 10-Q · filed 2013-02-11 |
| 2011-06-25 | $59.70M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $60.57M 10-K · filed 2012-03-14 | |
| 2010-06-30 | $87.40M 10-K · filed 2013-09-27 | |
| 2009-12-26 | $97.41M 10-K · filed 2012-03-14 | |
| 2008-12-27 | $121.38M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |